Atrial fibrillation (AF) is predictive of higher costs for stroke care, in part due to the influence
of AF on stroke severity. Costs associated with severe strokes, which are more likely in …

Introduction: Atrial fibrillation (AF) increases the risk of ischemic stroke 5‐fold and may not
only be responsible for as many as 15% of all strokes that occur but also for larger and more …

Atrial fibrillation (AF) is an independent predictor of stroke and heart failure. Stroke, in
particular, is more severe and costly in AF than in non-AF patients. Direct costs to Medicare …

OBJECTIVE To summarize the available evidence on the issues in health economics related
to oral anticoagulation for stroke prevention in atrial fibrillation (AF) in the US. DATA …

Atrial fibrillation (AF) is a common arrhythmia that significantly increases the risk of stroke by
the formation and embolism of left-atrial appendage thrombi. This risk can be substantially …

Background and Purpose—Stroke outcomes in patients with atrial fibrillation (AF) tend to be
worse than those in patients without AF. The objective of this study was to evaluate whether …

Using a disease model, the current economic burden of stroke in the 2.3 million US patients
with atrial fibrillation was estimated, and potential savings in direct costs obtainable by …

Our objective is to summarize the key components of a health economic evaluation of
antithrombotic treatments for stroke prevention in patients with atrial fibrillation (AF). The key …

Oral anticoagulant therapy is the mainstay of stroke prevention in patients with atrial
fibrillation; it is highly effective at reducing stroke risk, but its use can be limited by increased …

Some 3 million people in the United States have atrial fibrillation (AF). Without
thromboprophylaxis, AF increases overall stroke risk 5-fold. Prevention is paramount as AF …